InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

01 May 2025

Name:	JAYEX TECHNOLOGY LIMITED (JTL)
ISIN:	AU0000155293
Date of Listing:	17 December 2015
Date of Delisting:	06 August 2024
Former Names:

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 06 August 2024.

Legal Status: (updated monthly)

ACN: 119 122 477ABN: 15 119 122 477
Registration Date: 04 April 2006

To our knowledge this is a current registered entity, not in any form of external administration. If you have questions about your shareholding they may be taken up with us here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

The securities in this entity, in our opinion, are of little or no value. We have made that assessment by reference to the circumstances leading to a suspension and/or delisting, the length of a suspension, share trading history and last on-market share price, most recent financial and cash flow statements, prospects (including likelihood of re-financing), and other factors including in particular whether the entity is in external administration. If you are seeking to crystallise a capital loss on your securities, that process can be easily and quickly initiated at our online Worthless Shares facility here: https://www.delisted.com.au/sell-worthless-and-other-securities/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

JAYEX TECHNOLOGY LIMITED(JTL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
JAYEX HEALTHCARE LIMITED		01/06/2021

Shareholder links

Our website ranking of JTL:

(5 out of 5)

COMPANY WEBSITE:

JTL website

JTL email

JTL investorRelations

JTL announcements

JTL annualreports

JTL directors

REGISTRY:

Level 5, 191 ST GEORGES TERRACE PERTH WA 6000

Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
Fax :
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000155293

Address: Level 4, 100 Albert Road South Melbourne VIC 3205
Tel: +61 1300 799 365 Fax: +61 03 9077 9233

Date first listed: 17/12/2015
Company Secretary:
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities:

News & Events

Expand this box to read and print

Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.	13/09/2024
delisted at entity's request under Listing Rule 17.11	06/08/2024
we understand the company delisted from ASX because of the lack of liquidity on ASX, difficulties associated with fundraising as a listed company, a disproportionate impact on share price of the small number of trades on ASX, costs of the listing and the fact the company's business is now entirely based in the UK	06/08/2024
The company lodged its June 2024 Quarterly Activity Report and June 2024 Appendix 4C.	05/08/2024
The securities of the Company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Thursday, 1 August 2024, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Wednesday, 31 July 2024, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed.	01/08/2024
The suspension of trading in the securities of Jayex Technology Limited will be lifted from the commencement of trading on Monday, 6 May 2024 following lodgement of its Annual Report for the period ending 31 December 2023.	03/05/2024
The company releases its Appendix 4G and Corporate Governance Statement.	03/05/2024
The company releases its annual report.	03/05/2024
The securities of the company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Tuesday, 2 April 2024, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Thursday, 28 March 2024, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed.	02/04/2024
The securities of Jayex Technology Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of JTL, pending the release of its Annual Report for the year ended 31 December 2023.	28/03/2024
The suspension of trading in the securities of Jayex Technology Limited will be lifted from the commencement of trading on Friday, 30 July 2021 following the release by JTL of an announcement regarding a strategic investment.	30/07/2021
Jayex has signed a binding agreement for the investment of US$2 Million in cash into Brainworks' Foundry, Inc. Brainworks' AI technology platform is currently undergoing preliminary clinical trials and is designed to allow a patient's vital signs, incl. heart rate, respiratory rate, blood oxygenation to be measured simply by focusing a smart camera (phone, PC, TV) on the patient's face for 5-30 seconds. In addition, Brainworks has utilized existing technologies to develop a highly scalable polymerase chain reaction testing process, using next-generation gene sequencing and DNA barcoding that reduces cost and turnaround time. Post-COVID, Brainworks plans to diversify its platform to support additional viral and bacterial tests including influenza, Hepatitis, HIV, and other pathologies.	30/07/2021
The securities of Jayex Technology Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of JTL, pending the release of an announcement regarding a strategic investment.	28/07/2021
name changed from Jayex Healthcare Limited	01/06/2021

Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.	13/09/2024
delisted at entity's request under Listing Rule 17.11	06/08/2024
we understand the company delisted from ASX because of the lack of liquidity on ASX, difficulties associated with fundraising as a listed company, a disproportionate impact on share price of the small number of trades on ASX, costs of the listing and the fact the company's business is now entirely based in the UK	06/08/2024
The company lodged its June 2024 Quarterly Activity Report and June 2024 Appendix 4C.	05/08/2024
The securities of the Company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Thursday, 1 August 2024, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Wednesday, 31 July 2024, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed.	01/08/2024
The suspension of trading in the securities of Jayex Technology Limited will be lifted from the commencement of trading on Monday, 6 May 2024 following lodgement of its Annual Report for the period ending 31 December 2023.	03/05/2024
The company releases its Appendix 4G and Corporate Governance Statement.	03/05/2024
The company releases its annual report.	03/05/2024
The securities of the company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Tuesday, 2 April 2024, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Thursday, 28 March 2024, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed.	02/04/2024
The securities of Jayex Technology Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of JTL, pending the release of its Annual Report for the year ended 31 December 2023.	28/03/2024
The suspension of trading in the securities of Jayex Technology Limited will be lifted from the commencement of trading on Friday, 30 July 2021 following the release by JTL of an announcement regarding a strategic investment.	30/07/2021
Jayex has signed a binding agreement for the investment of US$2 Million in cash into Brainworks' Foundry, Inc. Brainworks' AI technology platform is currently undergoing preliminary clinical trials and is designed to allow a patient's vital signs, incl. heart rate, respiratory rate, blood oxygenation to be measured simply by focusing a smart camera (phone, PC, TV) on the patient's face for 5-30 seconds. In addition, Brainworks has utilized existing technologies to develop a highly scalable polymerase chain reaction testing process, using next-generation gene sequencing and DNA barcoding that reduces cost and turnaround time. Post-COVID, Brainworks plans to diversify its platform to support additional viral and bacterial tests including influenza, Hepatitis, HIV, and other pathologies.	30/07/2021
The securities of Jayex Technology Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of JTL, pending the release of an announcement regarding a strategic investment.	28/07/2021
name changed from Jayex Healthcare Limited	01/06/2021

Your browser may reflect a date of printing in American format.

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
04/04/2023	Michael Boyd	3,000,000	$0.010	$31,267.00
01/12/2022	Michael Chan	50,820	$0.012	$610.00
30/06/2021	Michael Chan	20,000	$0.027	$540.00
30/09/2020	Michael Boyd	1,500,000	$0.035	$52,500.00
30/06/2020	Michael Chan	24,962	$0.018	$449.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Michael Boyd	Executive Chairman	17/12/2015
Robert Hadley	CEO, CFO	03/10/2022
William Boyd	Non Exec Director	04/06/2024
Brian Renwick	Non Exec Director	17/12/2015
Melanie Leydin	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.